Abstract:Osteoclasts are the principal cells that efficiently resorb bone. Numerous studies have attempted to reveal the molecular pathways leading to the differentiation and activation of osteoclasts to improve the treatment and prevention of osteoporosis and other bone-destructive diseases. While the cumulative knowledge of osteoclast regulatory molecules, such as receptor activator of nuclear factor-kB ligand (RANKL) and nuclear factor of activated T cells 1 (NFATc1), contributes to the understanding of the developmental progression of osteoclasts, little is known about how the discrete steps of osteoclastogenesis modify osteoclast status but not the absolute number of osteoclasts. The regulatory mechanisms involved in osteoclast maturation but not those involved in differentiation deserve special attention due to their potential use in establishing a more effective treatment strategy: targeting late-phase differentiation while preserving coupled bone formation. Recent studies have shed light on the molecules that govern late-phase osteoclast differentiation and maturation, as well as the metabolic changes needed to adapt to shifting metabolic demands. This review outlines the current understanding of the regulation of osteoclast differentiation, as well as osteoclast metabolic adaptation as a differentiation control mechanism. Additionally, this review introduces molecules that regulate the late-phase osteoclast differentiation and thus minimally impact coupled bone formation.

What problem does this paper attempt to address?

The problem that this paper attempts to solve is related to the complex mechanisms in the process of osteoclast differentiation and maturation, especially how these processes are regulated and their potential applications in the treatment strategies for bone - destructive diseases. Specifically, the paper focuses on the following aspects: 1. **Regulatory mechanisms of osteoclast differentiation**: The paper explores the molecular signaling pathways in the process of osteoclasts transforming from mononuclear precursor cells to mature multinucleated cells, especially the role of the RANKL - RANK signaling pathway and its downstream effector molecules. This process involves changes in gene expression patterns, morphological changes, and metabolic processes. 2. **Regulatory mechanisms of osteoclast maturation**: Besides differentiation, the paper also particularly emphasizes the regulation of the osteoclast maturation stage, which is a less - studied aspect but is crucial for establishing more effective treatment strategies. The maturation stage mainly involves cell adhesion, fusion, motility, and the formation of actin rings. 3. **Metabolic adaptation as a differentiation control mechanism**: The paper points out that during the process of osteoclast differentiation, cells need not only to activate specific gene expression programs but also to activate metabolic programs to support their high - energy demands. This includes the enhancement of oxidative phosphorylation and glycolysis pathways, and how osteoclasts adjust their metabolic states under hypoxic conditions. 4. **Identification of late - differentiation molecules**: The paper introduces several molecules that regulate the late - stage differentiation of osteoclasts but have less impact on coupled bone formation. These molecules may become targets for future treatment of bone - destructive diseases, by selectively controlling bone destruction while avoiding inhibition of bone formation. In summary, this paper aims to deeply understand the specific mechanisms of osteoclast differentiation and maturation, especially those molecules that play a key role in late - stage differentiation, thereby providing a theoretical basis for the development of new treatment strategies, especially for osteoporosis and other bone - destructive diseases.

Unraveling the intricacies of osteoclast differentiation and maturation: insight into novel therapeutic strategies for bone-destructive diseases